Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161797-99-5

Description:

Nomen chemicum: Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatum

CAS: 161797-99-5

Puritas: >99.0% (HPLC)

Aspectus: lux Yellow ad Off-White pulveris

Medium Febuxostat (CAS: 144060-53-7);

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Febuxostat intermedia:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS, 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161797-99-5

Chemical Properties:

Nomen chemicum	Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus
Synonyma	Febuxostat intermedia
CAS Number	161797-99-5
CATTUS Number	RF-PI1122
Stock Status	In Stock, Productio Capacity 100 Tons/Anno
Formulae hypotheticae	C13H13NO3S
M. Pondus	263.31
Liquescens punctum	180℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Lux Yellow ut Off-White pulveris
Lepidium sativum	per HPLC;per HNMR
Damnum in Siccatio	<0.50%
Residere in Ighition	<0.30%
una immunditia	<0.50%
Totalis immunditias	<1.00%
Puritas / Analysis Methodus	>99.0% (by HPLC)
Test Standard	Enterprise Standard
Consuetudinem	Medium Febuxostat (CAS: 144060-53-7);

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-carboxylatus (CAS: 161797-99-5) adhibetur in synthesi Febuxostat (CAS: 144060-53-7), xanthine oxidase/xanthine dehydrogenas inhibitor.Usus est ad curationem hyperuricemiae et podagrae chronicae.40-120 mg/diei febuxostatae efficax probatum est in gradibus seri uratis deducendis, cum hyperuricemia aegrotis podagra administravit.Fabuxostat a Teijin pharmaceutica inventa et licentiata pharmaceutica TAP (quae nunc est pars Takedae Pharmaceuticorum) et probata in US est ad hyperuricemiam aegroti podagrae curandam.